COLOPHON
About Online TB-500
An independent editorial reading log on TB-500 and its parent thymosin beta-4 — a live transmission from the bathyal zone of the literature.
What this site is
Online TB-500 is an independent editorial project that publishes summaries of the peer-reviewed research literature on TB-500 — the N-acetylated LKKTETQ heptapeptide fragment of thymosin beta-4. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is structured as a reading log: each peer-reviewed finding is surfaced as a single specimen, cited to its source, and dated. The model is descent through a deep, mostly-empty literature — long stretches of quiet preclinical work punctuated by isolated points of light. The 1997 Malinda endothelial-chemotaxis paper. The 2004 Bock-Marquette Nature cardiac-repair paper. The 2023 RGN-259 neurotrophic-keratopathy Phase 3 result. The 2025 engineered tandem-Tβ4 corneal-healing work. Each surfaced as it is, with the citation visible.
The 'online' in the name
The 'online' modifier in onlinetb500.com is editorial framing. We use it in the sense of a live transmission — a remotely-operated reading log streaming up from the bathyal zone of the literature — not in the sense of an online store. The site sells nothing. It is a reading desk, not a vendor.
Editorial standards
Every quantitative claim on this site cites a peer-reviewed source. Doses, percentages, durations, half-lives, and effect sizes map to a numbered citation in the references index. The footer disclaimer is unique to this site; the editorial voice is consistent across all pages. We do not invent citations. We do not link to other portfolio domains. We do not write competitor trademarks. We do not provide dosing recommendations for humans.
What we do not do
We do not provide medical advice. We do not employ clinicians, pharmacists, or any healthcare staff. We do not manufacture, sell, or distribute TB-500, thymosin beta-4, or any related compound. We do not endorse the use of TB-500 in humans. We do not maintain a clinical service, a consultation service, or a prescription pathway. Editorial commentary on the published research is the entire scope of this site.